Fair Value Measurements and Investments (Tables)

3 Months Ended

Dec. 31, 2021

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Assets and Liabilities Measured at Fair Value on a Recurring Basis


	Fair Value Measurements Using Inputs Considered as
	Level 1				Level 2
	December 31, 2021		September 30, 2021		December 31, 2021		September 30, 2021
	(in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds	$	11,084	$	11,779	$	—	$	—
U.S. government-sponsored debt securities	—		—		541		100
U.S. Treasury securities	1,075		2,400		—		—
Investment securities:
Marketable equity securities	481		490		—		—
U.S. government-sponsored debt securities	—		—		510		245
U.S. Treasury securities	2,287		2,985		—		—
Other current and non-current assets:
Money market funds	4		4		—		—
Derivative instruments	—		—		408		410
Total	$	14,931	$	17,658	$	1,459	$	755
Liabilities
Accrued compensation and benefits:
Deferred compensation liability	$	209	$	167	$	—	$	—
Accrued and other liabilities:
Derivative instruments	—		—		62		109
Total	$	209	$	167	$	62	$	109

Schedule of Non-Marketable Equity Securities

The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of December 31, 2021 including cumulative unrealized gains and losses:


	December 31, 2021
	(in millions)
Initial cost basis	$	893
Adjustments:
Upward adjustments	818
Downward adjustments (including impairment)	(13)
Carrying amount, end of period	$	1,698

Unrealized gains and losses included in the carrying value of the Company’s non-marketable equity securities still held as of December 31, 2021 and 2020 were as follows:


	Three Months Ended December 31,
	2021		2020
	(in millions)
Upward adjustments	$	224	$	14
Downward adjustments (including impairment)	$	—	$	(2)